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Selective complexation of divalent cations by a
cyclic α,β-peptoid hexamer: a spectroscopic and
computational study†
E. De Santis,*‡a A. A. Edwards,a B. D. Alexander,b S. J. Holder,*c
A.-S. Biesse-Martin,d,e B. V. Nielsen,b D. Mistry,f L. Waters,f G. Siligardi,g R. Hussain,g
S. Faured,e and C. Taillefumier*d,e
We describe the qualitative and quantitative analysis of the complexation properties towards cations of a
cyclic peptoid hexamer composed of alternating α- and β-peptoid monomers, which bear exclusively
chiral (S)-phenylethyl side chains (spe) that have no noticeable chelating properties. The binding of a
series of monovalent and divalent cations was assessed by 1H NMR, circular dichroism, ﬂuorescence and
molecular modelling. In contrast to previous studies on cations binding by 18-membered α-cyclopeptoid
hexamers, the 21-membered cyclopeptoid cP1 did not complex monovalent cations (Na+, K+, Ag+) but
showed selectivity for divalent cations (Ca2+, Ba2+, Sr2+ and Mg2+). Hexacoordinated C-3 symmetrical
complexes were demonstrated for divalent cations with ionic radii around 1 Å (Ca2+ and Ba2+), while
5-coordination is preferred for divalent cations with larger (Ba2+) or smaller ionic radii (Mg2+).
Introduction
Naturally-occurring macrocycles containing peptidic α-amino
acids, including cyclic peptides and depsipeptides, represent a
major class of compounds with a broad range of biological
activities.1 Their biological properties are often associated to
their binding of metal cations. For example, the destruxins are
a family of cyclohexadepsipeptides capable of modifying
various Ca2+-dependent processes.2 The mycotoxins enniatins
are also a class of cyclodepsipeptides ionophores which trans-
port monovalent cations across biological membranes.3
In the realm of peptidomimetics, α-peptoids (poly-N-substi-
tuted glycines) are particularly attractive architectures that
were previously shown to bind metal ions forming metallo-
peptoids.4 Peptoid synthesis is straightforward and an extre-
mely high diversity of side chains is accessible.5 Their head to
tail macrocyclisation is also particularly facile due to the
inherent flexibility of the peptoid backbone.6 This also applies
to the formation of cyclic β-peptoids7 and analogous cyclic
alternated α,β-peptoids.8
Cyclic α-peptoids with 3,9 4, 6, 8 and 10 residues have been
shown to bind cations, particularly from the first group alkali
metals with selectivity depending on the ring size.10 For
example, 18-membered cyclohexamers showed a peak of
selectivity for Na+ and metallated structures could be charac-
terised in the solid state.10a,d These include the formation of
the first supramolecular 1D metal–organic framework (MOF)
based on a cyclic peptoid.10d In this MOF triggered by Na+,
N-methoxyethyl coordinating side chains participate to gene-
rate the supramolecular assembly. Recently, binding of Gd3+
cations was also demonstrated by cyclic α-hexapeptoids charac-
terized by the presence of six N-carboxyethyl side chains or
three N-methoxyethyl and three carboxyethyl side chains in
alternation.11 Interestingly, these side chains, which confer
aqueous solubility to the complexes, do not appear to have any
eﬀective role in Gd3+ coordination.
Herein we present the first reported metal binding ability of
a cyclic α,β-peptoid hexamer towards a selection of metal
cations. The 21-membered cyclopeptoid cP1 is characterised
by six chiral (S)-1-phenylethyl side chains (spe) that lack co-
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ordinating sites, so the binding was therefore envisaged via
the backbone amides (Fig. 1).
Results and discussion
Synthesis
The cyclic α,β-peptoid cP1 was synthesised by head to tail cycli-
sation of its linear precursor using a previously described
methodology.8
Briefly, the linear precursor was composed of (S)-N-(1-
phenylethyl)glycine and (S)-N-(1-phenylethyl)-β-alanine mono-
mers in alternation and was synthesised by a solution-phase
submonomer approach.12 The C-terminal tBu-capping group
of the synthesised linear peptoid was cleaved using trifluoro-
acetic acid and subsequent HATU-mediated cyclisation led to
cP1 in 64% yield (see ESI† for details).
Experimental design
Metal binding is a delicate equilibrium between host–guest,
host–solvent and guest–solvent interactions. Binding occurs
when the interaction between the host and guest overcomes all
of the other competing interactions. Thus, the experimental
design is essential for the correct evaluation and quanti-
fication of the binding event. In this study acetonitrile
(CH3CN) was selected due to its low cation-coordinating pro-
perties.13 CH3CN has also been extensively employed for con-
formational studies of α-, β- and α,β-peptoids. Cyclic
α-peptoids have already shown the ability to bind monovalent
cations in CD3CN by NMR.
10a In addition, its transparency in
the far and near regions of the UV spectrum makes it an ideal
solvent for spectroscopic studies. Picrate salts were used for
NMR analysis to facilitate the quantification of the salt concen-
tration, which was calculated from the aromatic region of the
spectrum (6–9 ppm). However, due to their limited UV trans-
parency, picrates were not used for circular dichroism (CD)
and fluorescence spectroscopies and perchlorates salts were
used instead. The choice of the perchlorate counter ions was
also supported by their ease of dissociation in CH3CN, which
was expected to facilitate the cation-peptoid binding.13,14
A range of metal ions with variable size, polarizability/charge
and association constant (Ka) in CH3CN were selected (Table 1)
to assess whether cyclic α,β-peptoid cP1 displayed any selective
metal binding ability among the cations listed in Table 1.
Metal ion complexation
1H NMR. The complexity of the 1H NMR spectra of cP1 in
diﬀerent solvents (acetone-d6, CDCl3 and CD3CN) revealed
several conformations in equilibrium on the NMR time scale,
giving us the opportunity to assess the binding of cations by
simplification of the spectra. The binding interaction between
cP1 and a series of metal ions was therefore investigated by
1H NMR in CD3CN. No spectral changes were observed upon
addition of a molar excess of sodium or potassium picrates to
cyclopeptoid cP1 (see ESI, Fig. S1†), indicating the absence of
binding. Conversely, a significant overall simplification of the
1H NMR spectra was observed upon addition of strontium or
calcium picrates, and to a lesser extent with magnesium
picrates (see ESI, Fig. S2†), indicating that metal binding
occurred. Binding of divalent cations (Sr2+, Ca2+, Mg2+ and
Ba2+)16 was also observed when using perchlorate counterions,
thus indicating that the counterion did not aﬀect binding
(Fig. 2).
Table 1 Metal ions investigated
Cation Ionic radiusa (Å)
Charge density
(charge Å−2) log Ka
b
+1 Na 1.02 0.076 0.91, 1.0015b
Ag 1.15 0.060 —
K 1.38 0.042 1.23, 1.5215b,c
+2 Mg 0.72 0.307 2.26, 2.3715d
Zn 0.74 0.291 1.6815e
Fe 0.78 0.262 —
Ca 1.00 0.159 2.44, 2.7415d
Sr 1.18 0.114 2.5815d
Ba 1.35 0.087 2.6915d
+3 Fe 0.55 0.789 —
a Ionic radius for coordination number VI.15a b log ka values for M
n+ +
nClO4
−→Mn+(ClO4
−)n in CH3CN.
Fig. 2 Binding of cP1 with perchlorate salts of divalent cations.
Qualitative 1H NMR spectra of cP1 alone and in the presence of
perchlorate salts at a molar ratio (metal/cP1) of 2.
Fig. 1 Chemical structure of 21-membered cyclic α,β-peptoid cP1.
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The 1H NMR spectrum of cyclopeptoid cP1 alone is charac-
terised by a number of benzylic proton resonances between
5 and 6 ppm. This is indicative of the simultaneous presence
of cis and trans amides along the backbone. According to
literature, for pe side chains, 1H NMR resonances between 5.5
and 6 ppm are associated with benzylic protons on cis amides
and those around 5 ppm are from benzylic protons on trans
amides.17 The average amide cis/trans ratio was estimated to
75 : 25 in CD3CN (Fig. 2, 3 and S2†). The addition of a molar
excess of metal ion typically resulted in a decrease of the
signal around 6 ppm thus indicating an increased population
of all-trans conformers. At the saturation point, no further
changes of the 1H NMR spectrum and the cis/trans ratio were
observed. To confirm this, a step-wise titration of strontium
perchlorate into cP1 was performed in CD3CN (Fig. 3 and S3†).
A simplification of the 1H NMR spectrum was observed in the
region between 5 and 6 ppm. Specifically, increasing the molar
ratio (Sr2+/cP1) from 0 to 3 determined a stepwise decrease of
the peak around 5.8 ppm with a corresponding increase in the
signal around 5 ppm (Fig. 3). This suggested that once the
metal complex was formed, the cyclopeptoid cP1 adopted an
all-trans conformation. A plot integration of peaks around
5.8 ppm versus the molar ratio clearly indicated that no further
changes in the 1H NMR spectrum were observed after a 1 : 1
stoichiometry was reached. The 1H NMR spectrum of the Sr2+/
cP1 complex showed a single set of signals for each α- and
β-monomer which therefore was indicative of a discrete confor-
mation with a 3-fold rotational symmetry. NMR temperature
studies and 2D experiments enabled full proton assignment of
the metal complex (Fig. S4 and Table S1†). Notably, the
1H NMR spectrum for the Ca2+/cP1 complex is very similar to
that of the Sr2+/cP1 complex thus also indicative of a 3-fold
symmetry (Fig. 2). In contrast the spectra for the Ba2+/cP1 and
Mg2+/cP1 complexes, whilst simpler than that of the peptoid
cP1 alone, are distinct from those of Sr2+/cP1 and Ca2+/cP1
complexes. For all of the metal complexes the cis to trans
conversion was complete upon addition of an excess of metal.
A cis to trans isomerisation was previously observed in cyclic
α-peptoid binding cations.10a,18
Circular dichroism. Circular dichroism (CD) was undertaken
to further probe and quantify the binding interaction using
either electronic CD (ECD) on a benchtop instrument or syn-
chrotron radiation CD (SRCD). CD is an invaluable technique
for the characterisation of binding19 due to its sensitivity to
subtle conformational changes in the far (160–250 nm) and
near (260–340 nm) UV regions, corresponding to electronic tran-
sitions of amide and aromatic chromophores, respectively.20
Changes in the CD spectrum of cyclopeptoid cP1 resulting
from metal binding can be used for its quantification. To
exclude the self-assembly of cyclopeptoid cP1 (i.e. host–host
interactions) a preliminary concentration study of cP1 was
undertaken (Fig. S5†). In the concentration range between
1 and 500 µM the CD spectra were largely similar, thus exclud-
ing intermolecular host–host interactions. The CD spectra
upon addition of the metal were therefore indicative of an
interaction between the cyclopeptoid cP1 and the metal.
The CD spectrum of cP1 is characterised by two negative
maxima at 203 and 222 nm (Fig. 4). Similar CD spectra
observed for α-peptoids in CH3CN have been assigned to
helical conformations.21 However, due to the cyclic nature of
the α,β-peptoid cP1, a helical conformation is unlikely and the
spectrum may instead arise from a twisted-like conformation.
Based on these observations and the complexity of the
1H NMR spectra at room temperature, the CD spectrum of
cylopeptoid cP1 is likely to indicate the presence of multiple
conformers rather than one dominant species and the
[θ]203 nm of 268 × 10
3 is therefore taken to be indicative of this.
In this case, this dynamic behaviour may be due to the intrin-
sic flexibility of the backbone derived from the presence of
β-residues and the cis/trans isomerism of tertiary amides.
Consistently with 1H NMR data, no binding was observed
with sodium and potassium cations as indicated by the lack of
Fig. 3 Quantitative titration by 1H NMR of cP1 with Sr(ClO4)2 at the
molar ratio indicated (left) and a plot of the area under the peaks at ca.
5.8 ppm against the molar ratio (right). All 1H NMR spectra were
recorded in CD3CN at 20 °C and using a peptoid concentration of
8 mM.
Fig. 4 CD spectra of cP1 alone and in the presence of perchlorate salts
at a molar ratio of 10. All CD spectra were recorded in CH3CN at 20 °C
using a peptoid concentration of 7.5 µM and a 0.4 cm pathlength cell
for Ca(ClO4)2, Mg(ClO4)2 and Ba(ClO4)2 and a peptoid concentration of
15 µM using a 1 cm pathlength cell for Sr(ClO4)2 and Fe(ClO4)3.
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spectral changes in the far UV CD, which was also reported for
silver, zinc and iron(II) (Fig. S6†). This was further confirmed
for sodium and zinc by quantitative CD titrations in the far UV
region (Fig. S7†). CD in the near UV and fluorescence spec-
troscopy also showed no significant spectral changes upon
addition of sodium perchlorate to cP1 (Fig. S8†). In contrast, a
significant change to the spectral features in the far UV was
observed upon addition of perchlorate salts of Ba2+, Ca2+, Fe3+,
Mg2+ and Sr2+ thus indicating metal complex formation
(Fig. 4, S8 and S9†). Spectroscopic studies by fluorescence and
in the near UV by CD showed significant changes upon
addition of magnesium perchlorate to cP1 further supporting
the metal binding (Fig. S8†).
Nearly identical spectral features were observed for cylo-
peptoid cP1 in the presence of Ca2+ or Sr2+. The CD spectra of
these metal complexes were characterised by one negative
maximum around 208 nm which was red shifted in compari-
son to the free cylopeptoid cP1. The CD spectrum in the pres-
ence of Ba2+ has two maxima (negative circa 204 nm, positive
circa 227 nm). The CD spectrum of the Ba2+ complex has
greater [θ] and the negative maximum is only marginally red
shifted relative to cP1 and the corresponding Ca2+/Sr2+ com-
plexes. The Mg2+/cP1 complex was characterised by a negative
maximum at 198 nm and a positive maximum centred at
222 nm with a component at 216 nm. The CD spectrum in
the presence of Fe3+ has two negative maxima (circa 197 nm
and circa 210 nm) and shows similarity to the Mg2+
profile based on the blue shift of the negative maxima relative
to cP1.
The similarity in appearance of the Sr2+/cP1 and Ca2+/cP1
CD spectra agrees well with the similarity of their 1H NMR
spectra. The diﬀerences between the CD spectra of these two
metal complexes and those with barium and magnesium were
also reflected in their 1H NMR spectra suggesting distinct con-
formational diﬀerences. Notably, all metal complexes were
found to have increased [θ] relative to cP1 alone which was
also consistent with the 1H NMR observation of a confor-
mational shift to population of all-trans isomers i.e. increased
ordering of the conformational preference of cP1.
Modelling of metal complexes. In an attempt to understand
the possible conformational models for the metal complexes,
the semi-empirical modelling method PM6 was utilised as
part of MOPAC. In agreement with the 1H NMR data, all metal
complexes were modelled in the all-trans forms. Preliminary
conformations were assessed following MM2 minimisations in
the gas phase before optimisation at the PM6 level in the gas
phase. The chosen structures were then optimised by PM6 in
acetonitrile using the COSMO solvation model intrinsic to
MOPAC. Initial models were constructed from the all-trans
form of the cyclopeptoid cP1 by placing the appropriate metal
ion at various positions about and in the ring structure fol-
lowed by minimisation using MM2 and then PM6. The relative
stability of the conformations, as judged from heats of for-
mation, for all complexes was principally dependent upon
(i) the number of carbonyls binding to the metal cation,
(ii) the arrangement of the carbonyls about the metal cation
and (iii) the orientations of the ethylphenyl substituents about
the ring in that order. A full discussion of all conformations of
all ion complexes is beyond the scope of this paper thus Sr2+/
cP1 will be used as an exemplar in the following discussion
(Fig. S20 and S21†). Structural optimisation in the gas
phase gave 4 co-ordinate (4 CvOs ligating Sr2+) and 6 co-ordi-
nate species (6 CvOs ligating Sr2+) with the 4 co-ordinate
systems possessing consistently higher heats of formation
(ΔHf ∼ 275 kJ mol) than the 6 coordinate. At least two distinct
co-ordination patterns involving 6 carbonyl co-ordination were
observed, one with ΔHf values circa 220 kJ mol−1 involving two
CvOs binding from above and four CvOs binding from
below the Sr2+ cation, relative to the plane of the ring. In con-
trast, the conformers approaching C3 symmetric arrangement
of CvOs about the Sr2+ (3 above and 3 below the plane of the
ring) gave significantly lower ΔHf values, from ∼212 kJ mol−1
down to ∼192 kJ mol−1. Since C3 symmetry was confirmed by
1H NMR system with the lowest ΔHf was chosen to investigate
the arrangement of ethylphenyl groups about the ring. Since
the ethylphenyl groups displayed full unhindered rotation
about the N–C bond this was an extensive conformational
space. To facilitate the search a simple system of varying the
arrangements of the ethylphenyl groups about the ring was
adopted; in essence systematically changing the C–N–C–C
dihedral angles to facilitate various conformational starting
structures based upon the relative orientation of the phenyl
group ‘above’ (up or u) or ‘below’ (down or d) the plane of the
ring relative to the other groups. This analysis revealed a rela-
tively flat potential energy surface about these conformers
(Fig. S21†) with minimum energy conformers possessing
ΔHf values from ∼180 to ∼196 kJ mol−1. However the confor-
mations starting from the alternating ethylphenyl (ududud)
starting point all gave lower heats of formation than any of the
other arrangements. Two minimum energy conformers pos-
sessed C3 symmetry, one with ΔHf = 184.6 kJ mol−1 and one
with ΔHf = 180.1 kJ mol−1. The geometries of these two confor-
mers were then optimised using PM6 with the COSMO sol-
vation model inherent in MOPAC. The former conformer did
not give a vibrational spectrum without negative frequencies.
The latter conformer with further optimisation gave rise to a
Sr2+/cP1 complex with three-fold symmetry (C3) about the
cyclic axis (Fig. 5 and S10†) with a vibrational spectrum free of
negative frequencies. A similar procedure was adopted for the
Ba2+ complex giving a Ba2+/cP1 complex with three-fold sym-
metry (C3) about the cyclic axis. This is in excellent agreement
with the NMR spectra (Fig. 2). The average metal–O bond
lengths were 2.49 (SD = ±0.05) Å for Sr–O and 2.35 (SD = ±0.04)
Å for Ba–O.
In contrast, the lowest energy conformers for both Mg2+/cP1
and Fe3+/cP1 complexes involved only 5 of the 6 carbonyls
coordinating to the metal centre. For these complexes the
average metal–O bond lengths for the 5 bonding carbonyls
were 1.98 (SD = ±0.03) Å for Mg2+/cP1 and 1.91 (SD = ±0.06) Å
for Fe3+/cP1 (Fig. 5 and S11a, c†). Consequently, these com-
plexes possessed no symmetry beyond their identity; again,
this is in accordance with the results from the 1H NMR for the
Paper Organic & Biomolecular Chemistry
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Mg2+/cP1 complex (Fig. 2). Replacing the Mg2+ and Fe3+ ions
in the sites of the Ca2+ or Sr2+ ions of the C3 symmetrical
complexes and optimising the geometry led to stable sym-
metrical C3 complexes of these metals (Fig. S11b and d†) but
their energies were significantly higher (Table S2†) than
those illustrated in Fig. 5. Similarly transposing the Ca2+/cP1
and Sr2+/cP1 complexes into those with Mg2+ or Fe3+ led to
rearrangement of the cyclic peptoid cP1 to facilitate 6 co-
ordinate carbonyl binding once again. It is uncertain as to
whether the metal complexes with Mg2+ and Fe3+ shown in
Fig. 5 are absolutely the lowest energy conformers due to the
range of conformational possibilities available to these com-
plexes however they are significantly lower in energy than any
6 coordinate species found.
The Ba2+/cP1 complex also showed 5 coordinate carbonyl
binding but unusually the cation itself was displaced from the
plane of the peptoid resulting in close contacts with three of
the phenyl groups (Fig. 5 and S12†). Thus average metal–O
bond lengths for 3 of the bonding carbonyls were 2.76 (SD =
±0.03) Å and for the other two = 2.56 (SD = ±0.01), with the
average C–Ba distance for the three coordinating phenyls
being 2.74 (SD = ±0.12) Å. Again, this lack of symmetry was
mirrored in the 1H NMR and support for the phenyl co-
ordination comes from the appearance of an upfield shifted
aromatic resonance at 6.51 ppm.
Overall, the semi-empirical modelling largely agrees with
the CD spectra in that the spectra for Ca2+/cP1 and Sr2+/cP1
complexes are virtually identical in line with identical pre-
dicted conformations. The maxima for the complexes of Ba2+,
Mg2+ and Fe3+ are distinct from those of Ca2+ and Sr2+.
However, whereas the negative maxima occur at similar posi-
tions for Mg2+/cP1 and Fe3+/cP1 (circa 197 nm) that of the Ba2+/
cP1 complex is unique (circa 204 nm) which is in line with the
distinct conformation predicted by modelling. Interestingly
the CD spectrum of the Fe3+/cP1 complex appears to consist of
at least one more distinct peak at circa 210 nm; one possibility
for this is that this peak arises from a certain proportion of the
complexes in solution adopting the higher energy 6-coordinate
C3 symmetry in equilibrium with the predominately 5-coordi-
nate species.
Quantification of binding
Given the conformational changes observed for cylopeptoid
cP1 upon binding and the sensitivity of CD to subtle confor-
mational changes, a stepwise titration of Sr(ClO4)2 into cylo-
peptoid cP1 was performed to give further insight into the
binding event (Fig. 6A). The titration showed a gradual
increase of the intensity of the CD spectrum for cP1 together
with a red shift by 5 nm of the negative maxima around
205 nm and the inversion of the sign for the maximum
around 230 nm. An isodichroic point was also observed at
218 nm suggesting a conformational change between two (or
more) diﬀerent conformational states. The diﬀerential CD
(ΔCD) signal was obtained by subtracting the CD spectrum of
cP1 and that of Sr2+ from that of the Sr2+/cP1 metal complex
for the diﬀerent molar ratios (Fig. S13†). Using the CD data, a
plot of the ΔAbsorbance (ΔA, where ΔA = ΔCD/32 980) at
230 nm as a function of the Sr2+ concentration yielded a dis-
sociation constant (Kd) of 11.9 ± 0.5 µM when fitted to the Hill
equation (R2 = 0.99) (Fig. 6B).22 It is of note that the value of
the Kd was independent of the wavelength selected and the
maximum at 231 nm was chosen due to the absence of any
significant wavelength shift. The Kd was of the same order of
magnitude as that previously reported for an α-peptoid
hexamer with benzyloxyethyl (be) side chains which was
shown to bind monovalent cations by quantitative 1H NMR.10a
This similarity indicated that the α,β-peptoid backbone
retained the ability to bind metal ions in the presence of the
Fig. 5 Minimum energy conformations for metal complexes predicted
by PM6 (COSMO) calculations. Hydrogens are omitted for clarity. The
Ca2+/cP1 complex is nearly identical to the Sr2+/cP1 complex (see ESI†).
Fig. 6 Quantitative titration of cP1 with Sr(ClO4)2 and Mg(ClO4)2. (A)
SRCD spectra of cP1 and Sr2+/cP1 complexes at the molar ratio indi-
cated. (B) Plot of ΔAbsorbance as a function of the Sr2+ concentration
and Sr2+/cP1 molar ratio ﬁtted to the Hill equation (R2 = 0.99). All
spectra were recorded in CH3CN at 20 °C with a cP1 concentration of
15 µM using a 1 cm pathlength cell. (C) ITC binding isotherm of Mg
(ClO4)2 titrated into cP1 (107 µM) in CH3CN at 20 °C. Diﬀerential power
signal measured for each injection during the experiment (top) and inte-
grated peak areas corresponding to the measured heat absorbed per
injection and the theoretical ﬁt to a one binding site model (bottom).
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more flexible β-residues and diﬀerent side chains, albeit with a
diﬀerent cation selectivity. No binding to the monovalent
cations investigated was observed for cP1.
A Yoe–Jones plot23 where the diﬀerential molar ellipticity at
the positive and negative maxima was plotted versus the molar
ratio (Sr2+/cP1) gave a stoichiometric point of 1.6 as indicated
by the projection of the inflection point on the x-axis
(Fig. S13†). This was not consistent with the stoichiometry
obtained by 1H NMR and may be rationalised on the basis of
the higher sensitivity of CD to subtle conformational changes.
Specifically, 1H NMR indicated changes to the cis/trans isomer-
isation up to a Sr2+/cP1 molar ratio of 1 indicating a 1 : 1 stoi-
chiometry. Any further structural rigidification, which does
not alter the cis/trans ratio or does not modify significantly the
ring conformation would not be detected by 1H NMR. By con-
trast, these would be detected by CD (as an increased signal
intensity) and may give rise to the higher stoichiometry
observed in comparison to 1H NMR.
Interestingly, when looking at the intensity and wavelength
position of the negative maximum at 207, whilst the intensity
increases up to a molar ratio of 2, a significant wavelength
shift only occurs up to a molar ratio of 1 (Fig. 6A and S14†).
Based on these observations and supported by the PM6 calcu-
lation showing the 1 : 1 complex as the most favourable, it is
reasonable to assume that the complex is characterised by a
1 : 1 stoichiometry and any further change in intensity of the
CD signal is likely to result from further structural rigidi-
fication and an increased population of metal complexes.
A similar trend was also observed for the other metal
complexes (Fig. S14†) for which similar binding aﬃnity
was observed between each metal and cP1 (Table 2 and
Fig. S15–S18†).
The Mg2+/cP1 complex gave a Kd of 12 ± 0.2 µM by CD and
this was largely comparable with that calculated by isothermal
titration calorimetry (ITC),24 which yielded a Kd of the same
order of magnitude (2.3 µM) (Fig. 6C). ITC also showed that
the binding event was endothermic, as indicated by the posi-
tive values for the heat exchange and the enthalpy value
(ΔHcal) of 6902 cal mol−1 with an entropic contribution (ΔScal)
of 49.2 cal mol−1. Using ITC, the projection of the mid-point of
the titration curve on the x axis provided the stoichiometry of
the binding which was found to be close to 1 : 1 (metal/
peptoid) suggesting an approximately equimolecular inter-
action. This stoichiometry was consistent with that deduced by
CD and with the PM6 calculations for the Mg2+/cP1 complex.
Unfortunately, quantitative studies by 1H NMR were hampered
by the significant signal overlap (Fig. S19†).
Binding selectivity
Based on size, there appears to be no correlation in the selecti-
vity of cP1 for divalent over monovalent cations, for example
the ionic radius of Na+ (not complexed by cP1), is very close
to that of Ca2+ (1.02 and 1.00 Å, respectively). However,
selectivity observed for divalent cations, seems to be at least in
part correlated with their greater charge density (Table 1).
Amide groups, especially the non-hydrogen-bonded carbonyl
groups of peptoid amides, represent polar coordination sites
with enhanced divalent ion sensitivity by comparison to pep-
tides and proteins.25 Our results agree well with the obser-
vations of Tinès et al. on the selectivity of tetralactam systems
for alkaline-earth over alkaline cations.26 Wipﬀ et al., by
working on calix[4]arene amide systems have also observed
that complexation of cations is strongly dependent on the
nature of the amide groups (primary, secondary and tertiary),
with the complexes involving tertiary amides being the most
stable.27 Consistent with our results, the higher Sr2+/Na+ and
Ca2+/Na+ selectivities (ca. 500 and 125, respectively) were
measured from calix[4]arene with tertiary amide-based
pendant groups. A comparison can also be made between the
symmetrical binding mode of Sr2+/cP1 and Ca2+/cP1 and the
S6-symmetry Sr
2+ complex identified in the solid state for a
cyclic α-hexapeptoid bearing be side chains.10a It is of note
that in this case the coordinating be side chains assume a
pseudo equatorial orientation and do not intervene in the
binding. Aﬃnity of cyclic α-hexapeptoids (18-membered rings)
for alkali metals has also been described, with a peak of
selectivity for Na+. However, a direct comparison with our
results is not fully relevant since the host cyclopeptoids
studied carry chelating side chains that were shown to partici-
pate in the binding.10d
With regard to the divalent cations, between each other the
charge density is not the only criterion to be considered, as
their diﬀerence in size also plays a significant role in their
binding selectivity. The divalent cations with the smallest
ionic radii (Mg2+, Zn2+ and Fe2+) bind to cP1 only if the associ-
ated charge density is very high. Thus, the hard Mg2+ cation
binds to cP1 whereas the Zn2+ and Fe2+ cations having slightly
lower charge density do not bind (Table 1). For the other diva-
lent cations tested (Ca2+, Sr2+ and Ba2+), even though their
charge density is lower, they have ionic radii ≥1 Å, thus are
more adapted to the cavity size, which facilitate their com-
plexation to cP1. Size of the cations also appears to influence
the final conformation of the complexes i.e. when the cation
radius is too large or too small the binding is 5 coordinate and
6 coordinate only obtainable for a specific range of ionic radii.
Despite these observations, the case for the role of the ionic
radius and charge density in predicting binding is not clear
cut. It would appear that a number of factors involving size,
charge density, enthalpy and entropy play a part for all of the
species involved, namely the cation, anion, acetonitrile and
Table 2 Binding aﬃnity expressed as dissociation constant (Kd) and
stoichiometry by CD
Complex Kd (µM)
Stoichiometry (Mtn+/cP1)
>210 nm <210 nm
Sr2+/cP1 11.9 ± 0.5 1.6 1.6
Mg2+/cP1 12 ± 0.2 1.5 1.5
Ca2+/cP1 8.2 ± 0.3 1.1 1.04
Ba2+/cP1 12.7 ± 8.6 1.1 1.2
Fe3+/cP1 1.2 ± 0.9 — 1.5
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peptoid. Surprisingly a clear correlation between the occur-
rence of binding is observed with the association constants of
the metal perchlorates in acetonitrile (Table 1, Fig. 7). The
metal perchlorates with low association constants in aceto-
nitrile (log Ka < circa 2) are not bound whereas all of the salts
possesing Ka values roughly an order of magnitude larger were
observed to bind.
The Ka values of the salts in acetonitrile can be taken as an
indication of the free energy change in solvating the ions.
A high dissociation (low association) is a reflection of the aﬃnity
of the salts for acetonitrile. The low dissociation constants
(high association) indicate a lower free energy change upon
solvation i.e. the solvation energy for the non-binding salts is
higher than that of the binding salts. Thus, there is a larger
thermodynamic penalty being paid by taking the non-binding
salts out of acetonitrile into the macrocyclic complex and con-
sequently the overall free energy change is positive. Since the
binding salts are highly associated in acetonitrile it can be
taken that the free energy penalty in removing them from the
coordination/solvation sphere of acetonitrile is lower and a
negative free energy results from this process. This is by no
means a conclusive correlation or interpretation of binding
selectivity but the correlation between Ka and binding is
striking.
Conclusion
We have shown for the first time clear evidence of the selective
complexation of divalent over monovalent cations by a
21-membered cyclopeptoid hexamer composed of α- and
β-monomers in alternation. This selectivity is diﬀerent to that
generally observed with α-cyclopeptoid hexamers (18-mem-
bered rings) which have mainly shown selectivity for mono-
valent cations. Besides NMR analyses, a detailed analysis of
cation binding was undertaken by CD, an invaluable technique
to assess subtle conformational changes. From detailed dis-
cussion of the combined spectroscopic data, in conjunction
with modelling, it is clear that a holistic approach is needed to
deduce the reasons for the unique binding behaviour of this
cyclic peptoid. Application of this work in a hydrophobic
environment could be envisaged e.g. to support selective ion
transport in membranes. Alternatively modifications of the
side chains could be explored to ascertain if aqueous solubility
can be achieved whilst maintaining complexation ability
which would allow a wider range of biological applications to
be considered.
Experimental
Synthesis and characterisation
CH2Cl2 was distilled under N2 from CaH2 and stored over 4 Å
molecular sieves. MeOH was distilled under N2 from CaH2 and
stored over 4 Å molecular sieves. EtOAc, CH2Cl2, cyclohexane,
and MeOH for column chromatography were distilled before
use. DMF and iPr2NEt were dried over 4 Å molecular sieves. All
other solvents and chemicals obtained from commercial
sources were used as received. Melting points were determined
on a Reichert microscope apparatus and are uncorrected.
Specific rotations were measured on a Jasco DIP-370 polari-
meter using a 10 cm cell. IR spectra were recorded on a
Shimadzu FTIR-8400S spectrometer equipped with a Pike
Technologies MIRacle™ ATR and ν are expressed in cm−1.
NMR spectra were recorded on a Bruker AC-400 spectrometer
or a Bruker AC-500 spectrometer. Chemical shifts are refer-
enced to the residual solvent peak and J values are given in Hz.
The following multiplicity abbreviations are used: (s) singlet,
(d) doublet, (t) triplet, (q) quartet, (m) multiplet, and (br)
broad. Where applicable, assignments were based on COSY,
HMBC, HSQC and J-mod-experiments. Flash chromatography
was performed with Merck silica gel 60, 40–63 μm. HRMS were
recorded on a Micromass Q-Tof Micro (3000 V) apparatus.
HPLC analysis was performed on a Waters 590 instrument
equipped with an Acclaim® 120 column (C18, 5 μm, 120 Å,
4.6 × 250 mm) and a Waters 484 UV detector.
Synthesis of cyclic α,β-peptoid cP1
To a solution of the linear α,β-hexapeptoid12 (427 mg,
0.40 mmol, 1.0 equiv.) in CH2Cl2 (0.10 M) at rt under Ar was
added TFA (1 mL per 1 mL CH2Cl2) and the resulting mixture
was stirred for 2 h at rt. The solvents were evaporated under
reduced pressure and the residue was dried in vacuo, yielding
the crude termini deprotected peptoid. To a solution of the
crude peptoid (5.0 mM) in CH2Cl2/DMF (4 : 1) at 0 °C under
Ar, enough iPr2NEt (approx. 5.0 equiv.) was added to turn the
mixture slightly basic. HATU (0.48 mmol, 1.2 equiv.) was
added and the resulting mixture was stirred for 3 d at rt. The
solvents were evaporated under reduced pressure and the
residue was taken up in EtOAc (approx. 1/4 of the volume used
for cyclization). The organic layer was washed with an equal
amount of water and the aqueous layer was extracted with
EtOAc (×1). The combined organic layers were dried over
MgSO4, filtered and concentrated under reduced pressure.
Flash column chromatography in EtOAc until the impurities
had passed followed by change to EtOAc/MeOH 97 : 3 yielded
cyclic peptoid cP1 (258 mg, 64%) as a colorless solid:
Rf (EtOAc/MeOH 97 : 3) = 0.85; mp = 131–133 °C; [α]21D = –156.2
(c 0.74, CHCl3);
1H NMR (400 MHz, acetone-d6): δ 7.84–6.70
Fig. 7 The average Ka for M
n+ + nClO4
− → Mn+(ClO4
−)n in CH3CN for
the metal cations illustrating binding and non-binding regimes.
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(30H, m, PhH), 6.08–5.60 (4.85H, m, NCHCH3), 5.50–5.42
(0.10H, m, NCHCH3), 5.24–4.93 (1.05H, m, NCHCH3),
4.56–3.56 (6H, m, 3 × NCH2CvO), 3.52–2.14 (12H, m,
3 × NCH2CH2CvO and 3 × NCH2CH2CvO), 1.70–1.34 (18H, m,
6 × NCHCH3);
13C NMR (100 MHz, acetone-d6): δ 173.4, 173.2,
173.2, 173.0, 172.9, 172.7, 172.7, 172.4, 172.1, 171.3, 171.2,
170.3, 169.8, 169.7, 169.5, 169.2 (6C, 6 × CvO), 144.0, 143.4,
143.2, 143.0, 142.9, 142.1, 141.8, 141.4, 141.1 (6C, Ph), 130.6,
130.5, 130.3, 130.2, 130.1, 130.0, 129.9, 129.8, 129.2, 129.0,
128.9, 128.8, 128.4, 128.1 (30CH, Ph), 56.8, 55.9, 55.8, 54.7,
54.3, 53.9, 53.5, 53.0, 52.8, 52.3, 51.9 (6CH, 6 × NCHCH3), 47.3,
46.9, 46.6, 46.5, 46.2 (3CH2, 3 × NCH2CvO), 42.5, 42.3, 42.0,
41.8, 40.8, 39.3, 39.1, 37.4, 36.9, 36.0, 35.1, 33.6 (6CH2,
3 × NCH2CH2CvO and 3 × NCH2CH2CvO), 20.1, 19.2, 18.7,
18.3, 18.2, 17.9, 17.8, 17.6, 17.5, 17.4, 17.0 (6CH3,
6 × NCHCH3); IR (ATR): 1647 (CvO, amide), 1495, 1451, 1414,
1377, 1341, 1283, 1234, 1206, 1186, 1074, 1030, 986, 914, 843,
783, 746; HRMS (TOF MS ES+) calcd for C63H72N6O6Na
[M + Na]+ m/z 1031.5411, found 1031.5417. HPLC (Water (0.1%
TFA)/MeCN 20 : 80, flow = 0.80): tr = 15.79 min, purity = 99.5%.
NMR study
1H NMR experiments were undertaken using a peptoid concen-
tration of 4 or 8 mM for all the spectra of the cyclopeptoid cP1
and the corresponding metal complexes. 1H NMR spectra were
measured in deuterated solvents (CDCl3, acetone-d6 and
CD3CN) on a 400 MHz Bruker AC-400 spectrometer or a Bruker
AC-500 spectrometer. NMR temperature studies were con-
ducted on a Bruker AC-500 spectrometer equipped with a
Bruker BVT3000 Variable Temperature Unit (using a
Eurotherm 902S temperature controller).
Sr2+/cP1 complex: 1H NMR (500 MHz, CD3CN, 293 K):
δ 7.42–7.15 (30H, m, PhH), 5.25 (3H, m, NCHCH3), 5.07 (3H, q,
J = 6.5 Hz, NCHCH3), 4.47 (3H, m, 3 × NCH2aCvO), 3.86 (6H,
m, 3 × NCH2bCvO, 3 × NCH2aCH2CvO), 3.25 (3H, m,
3 × NCH2bCH2CvO), 2.71 (3H, m, 3 × NCH2CH2aCvO), 2.32
(3H, m, 3 × NCH2CH2bCvO), 1.62, 1.57 and 1.49 (18H, 3xd, J =
6.8 Hz, 6 × NCHCH3);
13C NMR (100 MHz, CD3CN, 293 K):
δ 177.1 (3C, 3 × CvO), 171.9 (3C, 3 × CvO), 141.0, 140.1 (6C,
Ph), 129.8, 129.6, 128.8, 128.6, 127.9, 127.4 (30CH, Ph), 57.0
(3CH, 3 × NCHCH3), 56.4 (3CH, 3 × NCHCH3), 45.6 (3CH2,
3 × NCH2CvO), 40.3 (3CH2, 3 × NCH2CH2CvO), 35.0 (3CH2,
3 × NCH2CH2CvO), 19.0 (3CH3, 3 × NCHCH3), 18.2 (3CH3,
3 × NCHCH3).
Circular dichroism (CD)
CD samples were prepared by weighing accurately small
amounts of the appropriate compound using a calibrated
balance with accuracy of 0.002 mg (Sartorius CPA26P) or
0.001 mg (Mettler Toledo XS3DU). The solvent was added volu-
metrically to obtain a sample solution of appropriate concen-
tration. Circular dichroism analyses were performed either by
SRCD or ECD as indicated. SRCD spectra were recorded at
beamline B23 of the Diamond Light Source (UK) using an Olis
CD spectropolarimeter (Module B) equipped with a Peltier
temperature control system and fitted with a bespoke thermo-
stated cell holder.28 The following parameters were used for
SRCD: 4 acquisitions, 10 nm min−1 scan speed, 0.1 nm data
interval, 1.0 nm spectral band width, 4 s time constant,
260 nm–190 nm scan range. ECD spectra were recorded using
a Chirascan Plus instrument (Applied Photophysics Ltd)
equipped with a Peltier temperature control system. The fol-
lowing parameters were used for ECD: 4 aquisitions, 1 nm
step, 1 s time per point, 1.0 nm spectral band width, 260 nm–
190 nm range. The qualitative and quantitative CD titrations
were carried out in a stepwise manner by adding small ali-
quots (3–80 μl) of stock solutions of perchlorate salt of varied
concentrations (1, 2 or 3 mM) into a solution of the peptoid of
a fixed concentrations (7.5 or 15 μM in the far UV region using
0.4 or 1 cm rectangular pathlength quartz cuvettes from
Hellma and 600 μM in the far UV region using a 1 cm cylindri-
cal quartz cuvette). The titration was designed to reach the sat-
uration of the peptoid and a final dilution of the peptoid
inferior to 15%. An accurate and precise addition of the small
aliquots of the guest, was achieved using positive displacement
pipettes. Peptoid spectra (4 accumulations) were recorded at
20 °C in CH3CN. Solvent baseline spectra (4 accumulations)
were recorded in the same cell at proximal time and averaged.
The peptoid spectra were averaged to give a spectrum from
which the averaged baseline was subtracted. The resulting
baseline corrected spectrum was normalised for pathlength
and concentration to give the molar ellipticity ([θ], deg cm2
dmol−1). CD data from quantitative metal titrations were pro-
cessed and analysed using a proprietary software developed at
the beamline B23 at Diamond Light Source (UK). The software
processed the data by taking into account the baseline subtrac-
tion, the dilution of the host (peptoid) upon titration and any
contributions to the CD deriving from the guest (none for the
perchlorate). The binding constant was obtained by fitting of
experimental data expressed as ΔAbsorbance (ΔA, where ΔA =
ΔCD/32 980) into the Hill equation.22
Fluorescence spectroscopy
Fluorescence data were obtained at 20 °C using a Varian
Eclipse instrument equipped with a Peltier temperature
control system and a cell with 1 cm path length using a
peptoid concentration of 600 μM. Emission spectra were
recorded using the following parameters: 250 nm excitation
wavelength, 5 nm excitation and emission slit width.
Excitation spectra were recorded using the following para-
meters: 284 nm excitation wavelength, 5 nm excitation and
emission slit width. Solvent and metal blanks were also
recorded at a proximal time and showed no contribution to
the fluorescence in the spectral region investigated.
Isothermal titration calorimetry (ITC)
ITC experiments were undertaken using a GE Healthcare
microcalorimeter. The reference cell was filled with CH3CN,
the sample cell (1.8 mL) was filled with a solution of the
peptoid at a concentration of 107 μM and titrated with ali-
quotes (2 μL) of a solution of Mg(ClO4)2 placed in the syringe
(2.5 mM). ITC experiments were undertaken at 20 °C using the
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following experimental parameters: 145 injections, 200
seconds spacing between injections, 307 rpm stirring speed
and 5 μcal s−1 reference power. Titrations of the Mg(ClO4)2
into the solvent and of solvent into the peptoids were carried
out separately to account for the heats of dissolution and solu-
tion respectively and subtracted from the metal – peptoid titra-
tion. Each titration was repeated in triplicate to ensure accu-
racy of the data obtained but data presented herein were not
averaged.
Molecular modelling (PM6)
Initial models of the complexes were made using ChemDraw
(Version 15.0.0.106, Perkin Elmer Informatics) and Chem3D
(Version 15.0.0.106, Perkin Elmer Informatics). Initial geome-
try and conformer searches were conducted using the integral
MM2 force field facility in Chem3D.29 Fuller geometry and
conformer searches were conducted using the semi-empirical
method PM6 in MOPAC2009 via the Chem3D MOPAC inter-
face. Final geometries were first minimised in the gas phase
and then minimised and assessed using PM6 with the COSMO
model for acetonitrile (dielectric constant set at 37.5).30
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